Aquestive Therapeutics Inc (AQST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
Sales | 11,129 | 12,643 | 16,824 | 13,267 | 13,928 |
Cost of Goods | 5,420 | 3,506 | 4,787 | 5,592 | 4,973 |
Gross Profit | 5,709 | 9,137 | 12,037 | 7,675 | 8,955 |
Operating Expenses | 24,817 | 22,717 | 25,156 | 17,472 | 42,635 |
Operating Income | -18,688 | -13,074 | -12,327 | -9,205 | -32,707 |
Interest Expense | 1,937 | 1,926 | 1,924 | 1,933 | 1,927 |
Other Income | 153 | 274 | 307 | -3,900 | -1,859 |
Pre-tax Income | -20,472 | -14,726 | -13,944 | -15,038 | -36,493 |
Net Income Continuous | -20,472 | -14,726 | -13,944 | -15,038 | -36,493 |
Net Income | $-20,472 | $-14,726 | $-13,944 | $-15,038 | $-36,493 |
EPS Basic Total Ops | -0.82 | -0.59 | -0.69 | -0.64 | -1.90 |
EPS Basic Continuous Ops | -0.82 | -0.59 | -0.70 | -0.64 | -1.90 |
EPS Diluted Total Ops | -0.82 | -0.59 | -0.69 | -0.64 | -1.90 |
EPS Diluted Continuous Ops | -0.82 | -0.59 | -0.70 | -0.64 | -1.90 |
EBITDA(a) | $-17,536 | $-11,902 | $-11,173 | $-8,085 | $-31,465 |